These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2447826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Measurement of immunoreactive myelin basic protein peptide (45-89) in cerebrospinal fluid.
    Gupta MK, Whitaker JN, Johnson C, Goren H.
    Ann Neurol; 1988 Mar; 23(3):274-80. PubMed ID: 2454068
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. p-Cresol sulfate is the dominant component of urinary myelin basic protein like material.
    Cao L, Kirk MC, Coward LU, Jackson P, Whitaker JN.
    Arch Biochem Biophys; 2000 May 01; 377(1):9-21. PubMed ID: 10775436
    [Abstract] [Full Text] [Related]

  • 7. Molecular features of immunoreactive myelin basic protein in cerebrospinal fluid of persons with multiple slcerosis.
    Bashir RM, Whitaker JN.
    Ann Neurol; 1980 Jan 01; 7(1):50-7. PubMed ID: 6153878
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L, McLeod JG, Muir A, Hensley WJ.
    Clin Exp Neurol; 1987 Jan 01; 24():5-10. PubMed ID: 2478320
    [Abstract] [Full Text] [Related]

  • 10. Myelin basic protein fragments in urine.
    Norton WT.
    Ann Neurol; 1987 Nov 01; 22(5):656-7. PubMed ID: 2447827
    [No Abstract] [Full Text] [Related]

  • 11. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
    Warren KG, Catz I.
    Ann Neurol; 1987 Feb 01; 21(2):183-9. PubMed ID: 2435224
    [Abstract] [Full Text] [Related]

  • 12. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
    Whitaker JN, Layton BA, Herman PK, Kachelhofer RD, Burgard S, Bartolucci AA.
    Ann Neurol; 1993 Jan 01; 33(1):10-7. PubMed ID: 7684211
    [Abstract] [Full Text] [Related]

  • 13. Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis.
    Whitaker JN, Kachelhofer RD, Bradley EL, Burgard S, Layton BA, Reder AT, Morrison W, Zhao GJ, Paty DW.
    Ann Neurol; 1995 Oct 01; 38(4):625-32. PubMed ID: 7574459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
    Warren KG, Catz I, Johnson E, Mielke B.
    Ann Neurol; 1994 Mar 01; 35(3):280-9. PubMed ID: 7510098
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.
    Mastronardi FG, Mak B, Ackerley CA, Roots BI, Moscarello MA.
    J Clin Invest; 1996 Jan 15; 97(2):349-58. PubMed ID: 8567954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.